Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find

FHS
May 30, 2024
2:06 am

A new report from MS Australia reveals that the average time to diagnose multiple sclerosis is nearly four years, highlighting the urgent need for increased research investment and enhanced awareness.

Bristol Myers makes a $4.8B bet on KRAS, striking deal to acquire Mirati

Bristol Myers Squibb has signed a $4.8 billion deal to buy Mirati Therapeutics and its cancer drug Krazati, which targets what was once thought to

October 9, 2023

Marijuana rescheduling leaves regulators and sellers cautiously optimistic – The Cannabist

Related Articles A move by the Biden Administration to change how marijuana is treated by federal authorities was met with cautious approval by Massachusetts state

May 14, 2024

ChatGPT shines in medical summary task, struggles with field-specific relevance

Study assesses ChatGPT’s capability to summarize medical abstracts, revealing high efficiency in producing concise, accurate summaries but highlighting challenges in accurately assessing article relevance to

March 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.